Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118386) titled 'Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy: A Randomized Clinical Trial' on Feb. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)
Condition:
paclitaxel-induced peripheral neuropathy
Intervention:
Control group:Standard care
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-04
Target Sample Size: Control group:80;HBOT group:80;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org....